The sports medicine market size is projected to be worth US$ 1,157.0 million in 2023. The market is likely to reach US$ 2,062.7 million by 2033. The market is further expected to surge at a CAGR of 6.0% during the forecast period 2023 to 2033.
Key Market Trends and Highlights
Attributes | Key Insights |
---|---|
Sports Medicine Market Estimated Size in 2023 | US$ 1,157.0 million |
Projected Market Value in 2033 | US$ 2,062.7 million |
Value-based CAGR from 2023 to 2033 | 6.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for sports medicine rose at a 7.4% CAGR between 2018 and 2022. The global market for sports medicine is anticipated to grow at a moderate CAGR of 6.0% over the forecast period 2023 to 2033.
Report Attributes | Details |
---|---|
Market Value in 2018 | US$ 809.0 million |
Market Value in 2022 | US$ 1,078.0 million |
CAGR from 2018 to 2022 | 7.4% |
The sports medicine market experienced a significant growth during the historical period from 2018 to 2022. The market is being driven by several factors, including the increasing prevalence of sports injuries, the rising demand for minimally invasive surgical procedures, and the growing adoption of sports medicine technologies.
The prevalence of sports injuries is increasing due to factors such as the growing popularity of sports and the increasing intensity of competition. The demand for minimally invasive surgical procedures is rising due to their benefits over traditional surgical procedures, such as shorter recovery times and less pain.
The adoption of sports medicine technologies is growing due to their ability to improve the diagnosis, treatment, and prevention of sports injuries.
The forecast period from 2023 to 2033 is expected to see accelerated growth in the market. There is a growing demand for personalized sports medicine, which is tailored to the individual needs of each athlete. The adoption of wearable devices is growing due to their ability to track and analyze athletic performance and to identify potential injuries.
Artificial intelligence and machine learning are being used to develop new and innovative sports medicine technologies, such as virtual reality and augmented reality rehabilitation programs.
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by India and China. The countries are expected to lead the market through 2033.
Forecast CAGRs from 2023 to 2033
The United States | 2.7% |
---|---|
The United Kingdom | 3.9% |
India | 8.9% |
China | 7.7% |
Germany | 3.6% |
The sports medicine market in the United States expected to expand at a CAGR of 2.7% through 2033. The aging population in the United States is maintaining active lifestyles, leading to an increased prevalence of musculoskeletal issues and a greater need for sports medicine interventions.
Continuous advancements in medical technology, including minimally invasive surgical techniques, imaging technologies, and regenerative medicine, enhance the diagnosis and treatment of sports injuries.
The sports medicine market in Germany is anticipated to expand at a CAGR of 3.6% through 2033. Germany boasts advanced healthcare infrastructure and medical facilities, providing a strong foundation for the development and growth of the sports medicine market. Access to state of the art equipment and expertise supports the delivery of high quality sports medicine services.
Germany has a strong tradition of sports professionalism, with successful athletes and teams participating in various sports. The demand for specialized sports medicine services for professional athletes contributes to market growth.
The sports medicine market in India is poised to expand at a CAGR of 8.9% through 2033. Government initiatives to promote sports and physical fitness, including the development of sports infrastructure and programs, create an environment that fosters the growth of the sports medicine market.
The rise of sports tourism in India, with the country hosting various international sports events, contributes to the demand for sports medicine services, including medical support for athletes and attendees.
Sports medicine trends in China are taking a turn for the better. A 7.7% CAGR is forecast for the country from 2023 to 2033. The increasing adoption of e-commerce and digital health platforms in China facilitates access to sports medicine products, services, and information, contributing to market growth.
There is a growing need for high quality sports medicine services to support their training, recovery, and performance, as Chinese athletes participate in international sports competitions.
The integration of traditional Chinese medicine approaches within sports medicine practices provides a holistic approach to injury management and recovery, aligning with cultural preferences.
The sports medicine market in the United Kingdom is anticipated to expand at a CAGR of 3.9% through 2033. Continuous innovation in rehabilitation techniques, including the use of technology and evidence based approaches, supports the recovery of individuals with sports related injuries. The innovation contributes to the growth of sports medicine services.
The increasing emphasis on participation of women in sports has led to a growing awareness of gender specific health issues in athletics. Sports medicine services tailored to health needs of women, contribute to market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below table highlights how standalone analyzers segment is projected to lead the market in terms of product type, and is expected to account for a share of 55.9% in 2023.
Based on end user, the hospitals segment is expected to account for a share of 31.0% in 2023.
Category | Shares in 2023 |
---|---|
Standalone Analyzers | 55.9% |
Hospitals | 31.0% |
Based on product, the standalone analyzers segment is expected to continue dominating the sports medicine market. The segment is expected to account for a share of 55.9% in 2023.
Advances in technology, such as improved imaging capabilities, faster processing speeds, and enhanced diagnostic accuracy, can drive the adoption of standalone analyzers. There is a higher demand for diagnostic tools that can aid in early detection and prevention of sports related injuries, as awareness about preventive healthcare grows.
The growth of sports medicine as a specialized field may contribute to an increased demand for dedicated diagnostic equipment, including standalone analyzers. Support from government initiatives or increased funding in sports medicine research and healthcare infrastructure can positively impact the market, including the standalone analyzers segment.
In terms of end user, the hospitals segment is expected to continue dominating the sports medicine market. The segment is expected to account for a share of 31.0% in 2023.
Hospitals typically have advanced diagnostic equipment, surgical facilities, and a range of specialists, making them well suited to handle complex sports related injuries. The availability of state of the art technology in hospitals can attract patients seeking advanced medical care..
Hospitals often offer a multidisciplinary approach to sports medicine, involving various specialists such as orthopedic surgeons, physical therapists, sports medicine physicians, and rehabilitation experts. The comprehensive approach can attract patients seeking integrated and holistic care.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
Attribute | Details |
---|---|
Estimated Market Size in 2023 | US$ 1,157.0 million |
Projected Market Valuation in 2033 | US$ 2,062.7 million |
Value-based CAGR 2023 to 2033 | 6.0% |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | Value in US$ million |
Key Regions Covered | North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa |
Key Market Segments Covered | Product Application Region |
Key Countries Profiled | The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel |
Key Companies Profiled |
|
The market is expected to reach US$ 1,157.0 million in 2023.
The market is set to expand by a CAGR of 6.0% by 2033.
The market is forecast to reach US$ 2,062.7 million by 2033.
India is to be the top performing market, with a CAGR of 8.9% through 2033.
Standalone analyzers segment is preferred, and is expected to account for a share of 55.9% in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Body Reconstruction Products 5.3.1.1. Arthroscopy Devices 5.3.1.2. Meniscal Repair Device 5.3.1.3. Prosthetic Devices 5.3.1.4. Orth biologics 5.3.2. Body Support and Recovery Products 5.3.2.1. Braces and Supports 5.3.2.2. Compression Clothing 5.3.2.3. Accessories 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 6.3.1. Knee Injuries 6.3.2. Shoulder Injuries 6.3.3. Ankle & Foot Injuries 6.3.4. Back & Spine Injuries 6.3.5. Elbow & Wrist Injuries 6.3.6. Hip Injuries 6.3.7. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Product 15.1.2.2. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Product 15.2.2.2. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Product 15.3.2.2. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Product 15.4.2.2. By Application 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Product 15.5.2.2. By Application 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Product 15.6.2.2. By Application 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Product 15.7.2.2. By Application 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Product 15.8.2.2. By Application 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Product 15.9.2.2. By Application 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Product 15.10.2.2. By Application 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Product 15.11.2.2. By Application 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Product 15.12.2.2. By Application 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Product 15.13.2.2. By Application 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Product 15.14.2.2. By Application 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Product 15.15.2.2. By Application 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Product 15.16.2.2. By Application 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Product 15.17.2.2. By Application 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Product 15.18.2.2. By Application 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Product 15.19.2.2. By Application 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Product 15.20.2.2. By Application 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Product 15.21.2.2. By Application 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Product 15.22.2.2. By Application 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Product 15.23.2.2. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Arthrex, Inc. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. DePuy Synthes (J&J) 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Smith & Nephew Plc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Stryker Corporation 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Zimmer Biomet Holdings, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Olympus Movement Performance 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Karl Storz 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Tornier N.V. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Wright Medical Group N.V. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. DJO Global 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Ossur HF 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Medtronic Plc 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. CONMED Corporation 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports